key: cord-0701903-hegs1hhu
authors: Reuken, Philipp A.; Wüst, Michaela; Löffler, Bettina; Bauer, Michael; Stallmach, Andreas
title: Letter: SARS‐CoV‐2‐induced gastrointestinal inflammation
date: 2020-11-18
journal: Aliment Pharmacol Ther
DOI: 10.1111/apt.16087
sha: 800ee101ee89276c59d407385ad5f94cfd0164c7
doc_id: 701903
cord_uid: hegs1hhu

LINKED CONTENT This article is linked to Taxonera et al and Taxonera & Alba papers. To view these articles, visit https://doi.org/10.1111/apt.15804 and https://doi.org/10.1111/apt.16117

We read with great interest the study of Taxonera et al on diarrhoea in IBD patients with COVID-19. 1 One potential link between SARS-CoV-2 infection and intestinal inflammation may be the ACE2 receptor. 2 However, it remains unclear to what extent active SARS-CoV-2 replication occurs in enterocytes. 3 SARS-CoV-2 RNA should be tested for to ensure reliable patient access to FMT while maintaining the safety and quality of procedures.

Declaration of personal interests: All authors declare no potential conflict of interest regarding the current manuscript. 

2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases

Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors

Infection of bat and human intestinal organoids by SARS-CoV-2

Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and correlation to tissue damage. bioRxiv

Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels

Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19